The Next Ozempic? This Unapproved Peptide Comes With a Big Catch

Retatrutide is an experimental weight-loss peptide attracting attention online and among gym users.

Early trials suggest strong weight-loss effects, but the drug is not approved anywhere.

Experts warn of risks including gastrointestinal side effects, muscle loss, and unknown long-term safety.

Buying it through unofficial channels adds further danger from uncertain dosing, contamination, and poor product quality.